Fieldpoint Private Securities, LLC Cara Therapeutics, Inc. Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 120 shares of CARA stock, worth $600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120
Previous 120
-0.0%
Holding current value
$600
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CARA
# of Institutions
10Shares Held
826KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY745KShares$3.72 Million0.0% of portfolio
-
American Portfolios Advisors Holbrook, NY40.4KShares$202,1250.02% of portfolio
-
Rathbones Group PLC Liverpool, X020.2KShares$100,8200.0% of portfolio
-
Rothschild Investment Corp10.6KShares$53,0000.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ8.83KShares$44,1650.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $269M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...